Literature DB >> 29330397

Safety and efficacy of haploidentical stem cell transplantation for multiple myeloma.

Yao Chen1,2, Jin Lu1,2, Lan-Ping Xu1,2, Huan Chen1,2, Xiao-Hui Zhang1,2, Feng-Rong Wang1,2, Yu-Hong Chen1,2, Yu Wang1,2, Kai-Yan Liu1,2, Xiao-Jun Huang3,4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29330397     DOI： 10.1038/s41409-017-0069-1

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

1.  Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report.

Authors:  Firoozeh Sahebi; Laurent Garderet; Abraham S Kanate; Diderik-Jan Eikema; Nina Simone Knelange; Omar F Dávila Alvelo; Yener Koc; Didier Blaise; Qaiser Bashir; José M Moraleda; Peter Dreger; James F Sanchez; Stefan Ciurea; Harry Schouten; Nirav N Shah; Mareike Verbeek; Wolf Rösler; Jose L Diez-Martin; Stefan Schoenland; Anita D'Souza; Nicolaus Kröger; Parameswaran Hari
Journal:  Biol Blood Marrow Transplant       Date:  2018-09-20       Impact factor: 5.742

2.  Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myeloma.

Authors:  Yao Chen; Wei-Jun Fu; Lan-Ping Xu; Han-Yun Ren; Yong-Rong Lai; Dai-Hong Liu; Lin Liu; Zi-Min Sun; Yuan-Bin Wu; Xin Wang; Ling-Hui Xia; Ming Jiang; Tong-Lin Hu; Ding-Ming Wan; Xiao-Jun Huang
Journal:  Chin Med J (Engl)       Date:  2019-08-05       Impact factor: 2.628

Review 3.  Allogeneic Stem Cell Transplantation in Multiple Myeloma.

Authors:  Christine Greil; Monika Engelhardt; Jürgen Finke; Ralph Wäsch
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.